Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -11.900% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. COc1ccc(CCNC2=CC(=O)N(c3ccc(F)cc3)C2=O)cc1
b. CCN(CC)CCNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O.Cl
c. Clc1ccc(-c2csc(N/N=C/c3cccnc3)n2)c(Cl)c1
d. Cc1ccc(OCC(O)CN2CCOCC2)cc1C.Cl
e. CCCCNC(=O)/C(C#N)=c1\s/c(=C\c2ccccc2OC(F)F)c(=O)n1CCCOC
Answer: c. Clc1ccc(-c2csc(N/N=C/c3cccnc3)n2)c(Cl)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(-c2csc(N/N=C/c3cccnc3)n2)c(Cl)c1
Clc1ccc(-c2csc(N/N=C/c3cccnc3)n2)c(Cl)c1
4-(2,4-dichlorophenyl)-N-[(E)-pyridin-3-ylmethylideneamino]-1,3-thiazol-2-amine